Due to privacy laws the child's identity was not released. "It is a bit unpredictable, which is why it is very important for people to get the flu shot if they haven't got it already". Talk with your health care provider if you have concerns about getting the flu vaccine.
There have been 1,723 lab confirmed cases of the flu since September 1. Influenza can have symptoms such as fever, cough, sore throat, runny or stuffy nose, muscle or body aches, headaches and fatigue, public health officials said.
Cases for the most recent week fell to 357, compared to 396 reported in the previous week.
The CDC recommends that everyone 6-months-old and older get a flu shot every year.
Flu activity increases in October, with it peaking between December and February, according to the Centers for Disease Control. The H1N1 virus generally produces milder infections like Australia had last season.
This year's flu season is already making its first victims across the U.S. and Canada, as well.
Providence officials say last week more than 10 percent of people coming into the emergency room at Providence St. Peter in Olympia had flu-like symptoms and almost 20 percent of flu tests came back positive. Most of the deaths have been in the older population...65 or older. This season's batch, moreover, is being touted as much more effective than last year's.
"Last year it went all the way into spring", said Dr. Vincent Lee with Paragould Family Care. The shot is a vaccine that helps protect you against the seasonal flu virus.
Ottawa Public Health offers flu shots, by appointment, for children under five (613 580-6744).
Spencer Durham, an infectious disease expert in the Harrison School of Pharmacy at Auburn University, urges everyone to get vaccinated as we enter the peak of flu season.
People at high risk of complications who experience influenza-like illness should seek medical care without delay. "She had the flu for a couple of days at home, and like any parent would do, they treated it and gave her bed rest".
NCT03180801 is a randomized, double-blind, placebo-controlled single-center trial of 123 subjects in collaboration with to assess the efficacy and safety of two different formulation and dosing regimens of FLU-v vaccine administered in healthy adults.